ECM
VRTX icon

Eisler Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Eisler Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$868K Buy
2,314
+2,308
+38,467% +$965K ﹤0.01% 582
2025
Q2 		$2.67K Sell
6
-240
-98% -$111K ﹤0.01% 827
2025
Q1 		$119K Sell
246
-1,271
-84% -$592K ﹤0.01% 870
2024
Q4 		$616K Buy
+1,517
New +$703K ﹤0.01% 726

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Eisler Capital Management's VRTX Position: Q3 2025 in Review

Eisler Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 38,467% in Q3 2025, buying an estimated $965K and bringing the position to 2,314 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Eisler Capital Management first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Eisler Capital Management held 2,314 shares of Vertex Pharmaceuticals worth $868K as of Q3 2025.
  • Eisler Capital Management bought 2,308 Vertex Pharmaceuticals shares in Q3 2025, an estimated $965K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #582 holding.
  • Eisler Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.